A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms

A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms - A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046138

Enrollment

Registered

2021-11-25

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

somatic symptoms

Interventions

Video-conference based cognitive behavioral therapy for somatic symptoms (6weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Those who have received a diagnosis of somatic symptom disorder in DSM-5 (2) Patients who are between 20 and 65 years of age at the time of consent. (3) Patients who have received a written consent of their own free will after receiving sufficient explanation and understanding to participate in this study. (4) Those who understand cognitive-behavioral therapy and have the mental and physical condition to practice it continuously for at least two months. (5) Those who have the ability and environment to use the Internet and computers to receive remote cognitive behavioral therapy (vCBT) using a web conference system. Translated with www.DeepL.com/Translator (free version)

Exclusion criteria

Exclusion criteria: (1) Patients who are complicated by serious mental disorders such as DSM-5 neurocognitive disorder group, psychotic disorder, bipolar disorder, or substance-related disorder, and who are expected to discontinue cognitive behavioral therapy due to worsening of these symptoms. (2) Patients with mental retardation (referring to assessment scores such as JART-25: Japanese Adult Reading Test-25) or autism spectrum disorder (referring to AQ: Autism Spectrum Index, etc.). (3) Those who have a serious progressive physical disease that is expected to interrupt the study. (4) Patients who are judged by the principal investigator or the study psychologist to be inappropriate for the safe conduct of the study. (5) Persons whose physical symptoms involve litigation or compensation. Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

Measure	Time frame
MOS 36-Item Short-Form Health Survey Physical component summary Pre vCBTp Post vCBTp	—

Countries

Japan

Contacts

Public ContactHideki Nakamura

Graduate School of Medicine Chiba University Department of Cognitive Behavioral Physiology

cafa4942@chiba-u.jp043-226-2027

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026